Literature DB >> 19946101

Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.

B D Hayes1, A O'Doherty, C M Quinn.   

Abstract

AIMS: Needle core biopsy (NCB) is a widely-used technique for non-operative evaluation of screen-detected breast lesions. Although most NCBs are B2 (benign) or B5 (malignant), some fall into the B3 category of "uncertain malignant potential". This study aims to categorise the lesions prompting a B3 NCB in the Merrion Breast Screening Unit, and establish the incidence of malignancy on subsequent excision biopsy.
METHODS: Patients attending the Merrion Breast Screening Unit in Dublin between 2000 and 2008 who had a B3 NCB were identified. The NCB pathology reports were reviewed and the diagnosis correlated with excision histology; the latter was classified as benign, atypical or malignant. Lesion-specific positive predictive values (PPVs) for malignancy were derived.
RESULTS: 141 patients with a B3 NCB were identified. The most frequent lesions on NCB were radial scar (RS; n = 57), atypical intraductal epithelial proliferation (AIDEP; n = 25) and papillary lesion (n = 24). The final diagnosis was malignant in 22 patients (16%), atypical in 40 (28%) and benign in 79 (56%). Two of the patients with a malignant diagnosis had invasive carcinoma. The lesion-specific PPVs were: lobular neoplasia 50%, AIDEP 32%, columnar cell lesion with atypia 12.5%, RS 12.3%, papillary lesion 8.3%, suspected phyllodes tumour 7.7%, and spindle cell lesion 0%. Atypia on RS NCB predicted an atypical or malignant excision diagnosis, but atypia on papillary lesion NCB did not.
CONCLUSIONS: One-sixth of B3 NCBs in this series proved to be malignant on excision. The PPV for malignancy varied according to lesion type.

Entities:  

Mesh:

Year:  2009        PMID: 19946101     DOI: 10.1136/jcp.2009.067280

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  B3 Lesions: Radiological Assessment and Multi-Disciplinary Aspects.

Authors:  Sylvia H Heywang-Köbrunner; Jörg Nährig; Astrid Hacker; Stefan Sedlacek; Heinz Höfler
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

3.  Radial Scar at Image-guided Needle Biopsy: Is Excision Necessary?

Authors:  Niamh Conlon; Clare D'Arcy; Jennifer B Kaplan; Zenica L Bowser; Anibal Cordero; Edi Brogi; Adriana D Corben
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

4.  In vivo classification of breast masses using features derived from axial-strain and axial-shear images.

Authors:  Haiyan Xu; Tomy Varghese; Jingfeng Jiang; James A Zagzebski
Journal:  Ultrason Imaging       Date:  2012-10       Impact factor: 1.578

5.  Borderline breast lesions: comparison of malignancy underestimation rates with 14-gauge core needle biopsy versus 11-gauge vacuum-assisted device.

Authors:  Viviana Londero; Chiara Zuiani; Anna Linda; Luisa Battigelli; Giovanni Brondani; Massimo Bazzocchi
Journal:  Eur Radiol       Date:  2011-01-12       Impact factor: 5.315

Review 6.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

7.  Do clinical and radiologic features help predict malignancy of B3 breast lesions without epithelial atypia (B3a)?

Authors:  Iliana Bednarova; Viviana Londero; Anna Linda; Rossano Girometti; Michele Lorenzon; Sandra Bednarova; Chiara Zuiani
Journal:  Radiol Med       Date:  2018-07-05       Impact factor: 3.469

8.  Is mode of presentation of B3 breast core biopsies (screen-detected or symptomatic) a distinguishing factor in the final histopathologic result or risk of diagnosis of malignancy?

Authors:  Gael M Maclean; Stephen P Courtney; Hilary Umeh; Siriathan Sanjeev; Colin McCormick; Brendan M Smith
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

Review 9.  Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?

Authors:  Marco Lucioni; Chiara Rossi; Pascal Lomoro; Francesco Ballati; Marianna Fanizza; Alberta Ferrari; Carlos A Garcia-Etienne; Emanuela Boveri; Giulia Meloni; Maria Grazia Sommaruga; Elisa Ferraris; Angioletta Lasagna; Elisabetta Bonzano; Marco Paulli; Adele Sgarella; Giuseppe Di Giulio
Journal:  Eur Radiol       Date:  2020-08-20       Impact factor: 5.315

10.  Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management.

Authors:  Camilla Saladin; Harald Haueisen; Gert Kampmann; Christian Oehlschlegel; B Seifert; Luzi Rageth; Christoph Rageth; S Stadlmann; Rahel A Kubik-Huch
Journal:  Acta Radiol       Date:  2015-11-08       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.